Pfizer Inc., 10% Owner at AQUINOX PHARMACEUTICALS, INC (AQXP), sold 259,927 shares at $23.41 ($6.9M) on 2015-08-10, disclosed to the SEC on 2015-08-12.
Open-market sale of $6.9M AQXP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.35 | 25,931 | $528K | 7.7% |
| 2 | $21.45 | 8,969 | $192K | 2.8% |
| 3 | $22.60 | 44,268 | $1.0M | 14.5% |
| 4 | $23.41 | 58,632 | $1.4M | 19.9% |
| 5 | $24.31 | 31,400 | $763K | 11.1% |
| 6 | $25.32 | 12,726 |
| $322K |
| 4.7% |
| 7 | $26.32 | 13,109 | $345K | 5.0% |
| 8 | $27.36 | 8,565 | $234K | 3.4% |
| 9 | $28.47 | 2,975 | $85K | 1.2% |
| 10 | $29.00 | 18 | $522 | 0.0% |
| 11 | $35.61 | 3,207 | $114K | 1.7% |
| 12 | $36.37 | 10,544 | $383K | 5.6% |
| 13 | $37.23 | 9,901 | $369K | 5.4% |
| 14 | $38.49 | 11,627 | $448K | 6.5% |
| 15 | $39.52 | 9,142 | $361K | 5.3% |
| 16 | $40.30 | 6,073 | $245K | 3.6% |
| 17 | $41.25 | 2,840 | $117K | 1.7% |
| Total | $26.47 avg | 259,927 | $6.9M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $900K | — | Filing → |
| ALLO | BUY | 2018-10-17 | $1.0M | — | Filing → |
| RYTM | BUY | 2017-10-10 | $680K | — | Filing → |